176.37
+3.24(+1.87%)
Currency In USD
| Previous Close | 173.13 |
| Open | 173.23 |
| Day High | 176.68 |
| Day Low | 172.36 |
| 52-Week High | 176.68 |
| 52-Week Low | 93.58 |
| Volume | 33,058 |
| Average Volume | 271,827.4 |
| Market Cap | 3.46B |
| PE | -43.66 |
| EPS | -4.04 |
| Moving Average 50 Days | 154.82 |
| Moving Average 200 Days | 122.34 |
| Change | 3.24 |
If you invested $1000 in Ligand Pharmaceuticals Incorporated (LGND) 10 years ago, it would be worth $3,300.89 as of September 30, 2025 at a share price of $176.37. Whereas If you bought $1000 worth of Ligand Pharmaceuticals Incorporated (LGND) shares 5 years ago, it would be worth $2,966.02 as of September 30, 2025 at a share price of $176.37.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ligand to Participate in September Investor Conferences
GlobeNewswire Inc.
Aug 19, 2025 8:00 PM GMT
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investo
Ligand Announces Closing of Convertible Senior Notes Offering
GlobeNewswire Inc.
Aug 14, 2025 8:00 PM GMT
JUPITER, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today that it completed its previously announced offering (the “offering”) of 0.75% convertible senior notes due 2030 (the “not
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
GlobeNewswire Inc.
Aug 12, 2025 3:46 AM GMT
JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a pr